Therapeutic Drug Monitoring Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Therapeutic Drug Monitoring Industry Market Size Be by 2025?
The market size for therapeutic drug monitoring has seen substantial expansion in the recent past. The market, which is poised to escalate from $2.23 billion in 2024 to $2.41 billion in 2025, is predicted to experience a compound annual growth rate (CAGR) of 8.1%. The surge during the historical period can be linked to an increase in chronic diseases, apprehensions about drug safety, the incorporation of pharmacogenomics, acceleration in drug development, and regulatory focus on precision medicine.

What's the Long-Term Growth Forecast for the Therapeutic Drug Monitoring Market Size Through 2029?
The market size for therapeutic drug monitoring is projected to undergo a swift expansion in the ensuing years, with an estimated value of $3.67 billion in 2029, rising at a compound annual growth rate (CAGR) of 11.1%. The predicted growth during this period can be attributed to a variety of factors including an increase in oncology applications, a surge in personalized medicine practices, a global rise in the aging population, a broader range of point-of-care testing, and a growth in pharmaceutical R&D expenditure. During the forecast period, the major market trends are expected to encompass personalized medicine, advances in technology, an upsurge in drug development and utilization, point-of-care testing (POCT), and the emergence of novel biomarkers and assay technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

What Are the Key Growth Drivers Fueling the Therapeutic Drug Monitoring Market Expansion?
The growth of the therapeutic drug monitoring market is predicted to be fueled by the increasing number of organ transplant operations. The surgical procedure of transferring an organ from a donor to a recipient, known as organ transplantation, is becoming more common. The therapeutic drug monitoring (TDM) of immunosuppressive drugs is acknowledged as an efficient way of managing patients who have undergone solid organ transplants. Through TDM optimization, it's possible to prevent harmful or insufficiently low-dose treatments that may lead to organ rejection. For example, an article published by the United Network for Organ Sharing, a non-profit organization in the US that oversees organ transplants, revealed that in 2022 in the US, there were 42,887 organ transplants, marking a 3.7% increase from 2021. Hence, the rise in organ transplant operations is contributing to the growth of the therapeutic drug monitoring market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

What Are the Key Trends Driving Therapeutic Drug Monitoring Market Growth?
In the therapeutic drug monitoring market, leading firms are concentrating their efforts on innovating anti-idiotypic antibody technology. The objective of this focus is to augment assay sensitivity and specificity for the purpose of precisely gauging biologic drug amounts and monitoring patient immune responses. The application of anti-idiotypic antibody technology in therapeutic drug monitoring facilitates the exact identification and quantification of biologic drug levels. This ensures the correct dosage is administered and enables monitoring of patient immune responses. For example, in June 2024, US-based biotechnology firm, Bio-Rad Laboratories, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies. These are used in bioanalytical assays to enhance pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These cutting-edge antibodies are critical for the therapeutic drug monitoring market as they enhance assay reliability for antibody-drug conjugates (ADCs), and permit accurate evaluation of drug levels and immune responses, thereby ensuring optimal patient dosing.

How Is the Therapeutic Drug Monitoring Market Segmented?
The therapeutic drug monitoring market covered in this report is segmented -

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10069&type=smp

Which Companies Are Leading the Charge in Therapeutic Drug Monitoring Market Innovation?
Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

Which Regions Are Leading the Global Therapeutic Drug Monitoring Market in Revenue?
North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10069

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.